Breast Cancer Trial, Recruiting NCT07423039 Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07423039
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are female.
  • People who have been diagnosed with breast cancer and are scheduled to have therapeutic breast surgery at Robert Bosch Hospital as part of their initial treatment.
  • People who have signed the official consent form for the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with an anxiety disorder within the last 12 months.
  • People whose mental state, in the opinion of the trial investigator, would prevent them from taking part in the study.
  • People who use hearing aids.
  • People who have skin irritations or eczema in the ear.
  • People who are pregnant.
  • People who do not have sufficient knowledge of German.
  • People who are unwilling to allow their personal medical data to be stored and shared as required by the trial protocol.
  • People who have not provided a complete and signed declaration of consent.
  • People who have received acupuncture treatment (including NADA ear acupuncture or acupressure) in the last three months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marcela Winkler, Dr. med., Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

Phone: +4915774281360

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
30 June 2027

Primary endpoints

Anxiety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov